Canada
Industry
BMI View: Canada's healthcare system is under increasing financial pressure. Healthcare costs are rising because of the country's demographic trends, particularly its ageing-population....
2010-08-20Industry
Biovail posted pharmaceutical sales growth of 23% for Q210, with sales increasing to US$231.2mn compared with US$187.7mn in the same period in 2009. Second-quarter Generally Accepted...
2010-08-09Industry
In order to contain rising healthcare costs in British Columbia, the price of generic drugs covered by PharmaCare are to be reduced to 35% of the price of their branded counterparts,...
2010-07-12Industry
Research and development (R&D) spending by brand-name drug companies in Canada has dropped to its lowest level in 20 years, according to the latest annual report of the Patented...
2010-06-29Industry
BMI Core View: M&A activity will increase due to the efficiencies realised from
2010-06-22Industry
Despite the process being illegal, the cardiovascular drug Plavix (clopidogrel bisulphate) is the number one drug ordered online from Canada by US residents, according to the Canadian...
2010-06-10Industry
BMI Core View: Uptake of generic drugs following patent expiry will become swifter. This trend will reduce costs for governments, out-of-pocket payers and insurance companies, an increasingly...
2010-05-21Industry
BMI Core View: Many developed countries will overhaul their healthcare systems in a bid to reduce the escalating costs of
2010-05-11
